RSSL helps pharmaceutical and medical device companies rapidly authenticate suspect products, packaging and components safeguarding supply chains and supporting regulatory investigations.
Counterfeit medicines and device components present a critical risk to patient safety, regulatory compliance and brand trust. Whether you’re facing a suspected falsified drug product, unauthorised distribution, tampered packaging or unexplained performance failures, RSSL provides fast, reliable counterfeit analysis to confirm authenticity and give you clear evidence for corrective action.
Counterfeit investigations can arise at various points within the supply chain from multiple sources such as suspected falsified products, complaints and product quality concerns through to the authentication of returned, diverted or parallel goods. RSSL provides rapid, expert support to help maintain compliance and safeguard reputation whether that’s when packaging or component integrity is questioned or when data is needed to verify the legitimacy of a supplier or distributor.

We combine advanced analytical science with deep regulatory knowledge to give you rapid clarity and confidence during counterfeit investigations. Our experts deliver fast confirmation of authenticity or falsification, supported by root-cause understanding.
From identifying alternative ingredients, impurities and undeclared materials to uncovering physical or compositional differences. We provide clear, defensible evidence suitable for MHRA, FDA and internal investigations, backed by a robust GMP compliant quality system.
To ensure the strongest scientific outcome, we select techniques according to the evidence required for each case. Typical methods can include:

We also apply a range of specialist investigative tools where appropriate, including:
Suspected falsified product
Complaint / quality concern
Questioned packaging or component integrity
Returned / diverted / parallel stock
Risk assessment
Review of reference materials / exemplars
Define required evidence (chemical, physical, etc.)
Select priority techniques
Tailor method panel to the case requirements
Determine destructive vs non-destructive testing
Prepare chain-of-custody
Chemical Analysis: LC‑MS, GC‑MS, NMR
Spectroscopy & Material Analysis: FT‑IR, Raman, Microscopy
Physical & Visual Examination: Micro‑CT, Colourimetry
Mechanical, thermal & particulate testing
Match vs authentic reference
Assess chemical, structural & visual deviations
Determine conformity or falsification likelihood
Match vs authentic reference
Assess chemical, structural & visual deviations
Determine conformity or falsification likelihood
Clear, defensible findings
Evidence suitable for MHRA / FDA / internal use
Recommendations for corrective action
Supplier verification
Packaging design improvements
Repeat monitoring or extended analysis